IL95614A0 - Pharmaceutical compositions comprising an antibacterial compound and an absorption enhancing system - Google Patents
Pharmaceutical compositions comprising an antibacterial compound and an absorption enhancing systemInfo
- Publication number
- IL95614A0 IL95614A0 IL95614A IL9561490A IL95614A0 IL 95614 A0 IL95614 A0 IL 95614A0 IL 95614 A IL95614 A IL 95614A IL 9561490 A IL9561490 A IL 9561490A IL 95614 A0 IL95614 A0 IL 95614A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- antibacterial compound
- enhancing system
- absorption enhancing
- absorption
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40549489A | 1989-09-11 | 1989-09-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL95614A0 true IL95614A0 (en) | 1991-06-30 |
Family
ID=23603936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL95614A IL95614A0 (en) | 1989-09-11 | 1990-09-07 | Pharmaceutical compositions comprising an antibacterial compound and an absorption enhancing system |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0418674A1 (xx) |
JP (1) | JPH03106827A (xx) |
AU (1) | AU6236090A (xx) |
CA (1) | CA2024887A1 (xx) |
HU (1) | HU207216B (xx) |
IE (1) | IE903285A1 (xx) |
IL (1) | IL95614A0 (xx) |
ZA (1) | ZA906186B (xx) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5136105A (en) * | 1991-03-28 | 1992-08-04 | Union Carbide Chemicals & Plastics Technology Corporation | Oxidation of terminal olefins to aldehydes |
SI9400338A (en) * | 1994-08-31 | 1996-04-30 | Lek D D | Vancomycin hydrochloride suspensions for peroral use and for filling into soft ,gelatine capsules. |
GB9516268D0 (en) * | 1995-08-08 | 1995-10-11 | Danbiosyst Uk | Compositiion for enhanced uptake of polar drugs from the colon |
GB2318056B (en) * | 1995-08-08 | 1999-05-26 | Danbiosyst Uk | Composition for enhanced uptake of polar drugs from the colon |
JP2007042005A (ja) * | 2005-08-05 | 2007-02-15 | Toppan Forms Co Ltd | メールアドレス収集方法、情報処理サーバおよびメールアドレス収集システム |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4525339A (en) * | 1982-10-15 | 1985-06-25 | Hoffmann-La Roche Inc. | Enteric coated oral dosage form |
EP0126348A2 (en) * | 1983-05-19 | 1984-11-28 | Kyoto Pharmaceutical Industries, Ltd. | Composition for rectal administration and method of promoting rectal drug absorption |
CA1256799A (en) * | 1984-02-22 | 1989-07-04 | Walter Fuller | Suppositories |
-
1990
- 1990-08-06 ZA ZA906186A patent/ZA906186B/xx unknown
- 1990-09-07 EP EP90117309A patent/EP0418674A1/de not_active Withdrawn
- 1990-09-07 CA CA002024887A patent/CA2024887A1/en not_active Abandoned
- 1990-09-07 IL IL95614A patent/IL95614A0/xx unknown
- 1990-09-07 HU HU905823A patent/HU207216B/hu unknown
- 1990-09-10 AU AU62360/90A patent/AU6236090A/en not_active Abandoned
- 1990-09-10 JP JP2239807A patent/JPH03106827A/ja active Pending
- 1990-09-10 IE IE328590A patent/IE903285A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2024887A1 (en) | 1991-03-12 |
EP0418674A1 (de) | 1991-03-27 |
JPH03106827A (ja) | 1991-05-07 |
IE903285A1 (en) | 1991-04-10 |
HUT56269A (en) | 1991-08-28 |
ZA906186B (en) | 1991-06-26 |
HU905823D0 (en) | 1991-03-28 |
AU6236090A (en) | 1991-03-14 |
HU207216B (en) | 1993-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9025491D0 (en) | Pharmaceutical compositions | |
IL94821A0 (en) | Monosaccharide compounds and pharmaceutical compositions containing the same | |
GB8904182D0 (en) | Pharmaceutical compositions | |
GB8909022D0 (en) | Pharmaceutical compositions | |
NZ233011A (en) | Thieno-triazole-diazepine and pharmaceutical compositions | |
EP0409499A3 (en) | Pharmaceutical compositions | |
IL95614A0 (en) | Pharmaceutical compositions comprising an antibacterial compound and an absorption enhancing system | |
GB2232891B (en) | Pharmaceutical composition | |
GB8909906D0 (en) | Pharmaceutical compositions | |
ZA905512B (en) | Pharmaceutical compositions | |
ZA905671B (en) | Topical pharmaceutical compositions | |
NZ230703A (en) | Substituted benzoxazolones and pharmaceutical compositions | |
ZA90476B (en) | Pharmaceutical composition | |
GB8916657D0 (en) | Pharmaceutical composition | |
IE890696L (en) | Pharmaceutical composition | |
GB8907172D0 (en) | Pharmaceutical composition | |
IE892553L (en) | Pharmaceutical composition | |
GB8901235D0 (en) | Pharmaceutical composition | |
GB8921274D0 (en) | Pharmaceutical composition | |
GB8909692D0 (en) | Pharmaceutical composition | |
GB8900952D0 (en) | Pharmaceutical composition | |
GB8928855D0 (en) | Pharmaceutical composition | |
GB8915044D0 (en) | Pharmaceutical compositions | |
GB8919446D0 (en) | Pharmaceutical compositions | |
GB8919447D0 (en) | Pharmaceutical compositions |